Author | Lisa M. Holle, PharmD, BCOP, FHOPA

Articles

Why You Should Become Board Certified in Oncology

June 11, 2018

New developments in cancer treatment require medication experts-here's how you can become that expert.

Atezolizumab for Urothelial Carcinoma and Non-Small Cell Lung Cancer

February 08, 2017

Here: an overview of atezolizumab, the first new drug in two decades for bladder cancer and now approved for NSCLC.

FDA approves lixisenatide for type 2 diabetes

December 19, 2016

New drug review

Ixazomib for multiple myeloma

November 11, 2016

FDA approved ixazomib (Ninlaro, Takeda) in combination with lenalidomide and dexamethasone